Antimicrobial peptides of leukocytes

Current Opinion in Hematology

Volumn 4, Issue 1, 1997, Pages 53-58

  Ganz, Tomas ^a   Lehrer, Robert I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPROTECTIN; LACTOFERRIN; LYSOZYME; PHOSPHOLIPASE A2;

ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; CELL KILLING; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENTAMOEBA HISTOLYTICA; HUMAN; HUMAN TISSUE; KILLER CELL; LEUKOCYTE FUNCTION; MOLECULAR INTERACTION; PEPTIDE SYNTHESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0031046654     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704010-00009     Document Type: Review

References (75)

1. Albina JE: On the expression of nitric oxide synthese by human macrophages: why no NO? J Leukoc Biol 1995, 58:643-649.
2. Padgett EL, Pruett SB: Rat, mouse and human neutrophils stimulated by a variety of activating agents produce much less nitrite than rodent macrophages. Immunology 1995, 84:135-141.
3. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ: Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 1989, 142:4428-4434.
4. Garcia-Penarrubia P, Bankhurst AD, Koster FT: Experimental and theoretical kinetics study of antibacterial killing mediated by human natural killer cells. J Immunol 1989, 142:1310-1317.
5. Muth SM, Murphy JW: Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-lmmunized mice. Infect Immun 1995, 63:1637-1644.
6. Andersson M, Gunne H, Agerberth B, Boman A, Bergman T, Sillard R, Jornvall H, Mutt V, Olsson B, Wigzell H: NK-lysin, a novel effector peptide of cytotoxic T and NK cells: structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J 1995, 14:1615-1625.
7. Levy O: Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol 1996, 56:263-277. A very comprehensive and up-to-date review.
8. Gabay JE, Heiple JM, Cohn ZA, Nathan CF: Subcellular location and properties of bactericidal factors from human neutrophils. J Exp Med 1986, 164:1407-1421.
9. Leffell MS, Spitznagel JK: Fate of human lactoferrin and myeloperoxidase in phagocytizing human neutrophils: effects of immunoglobulin G subclasses and immune complexes coated on latex beads. Infect Immun 1975, 12:812-820.
10. Wright DG, Gallin JI: Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol 1979, 123:285-294.
11. Cowland JB, Johnsen AH, Borregaard N: hCAP-18, a cathelin/probactenecin-like protein of human neutrophil specific granules. FEBS Lett 1995, 368:173-176. This is a report of the isolation and sequencing of the precursor of the human cathelicidin from specific granules.
12. Santhangopalan V, Hahn BL, Dunn BE, Weissner JH, Sohnle PG: Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants. Clin Immunol Immunopathol 1995, 76:285-290.
13. Brandtzaeg P, Gabrielsen TO, Dale I, Muller F, Steinbakk M, Fagerhol MK: The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 1995, 371A:201-206.
14. Weinrauch Y, Foreman A, Shu C, Zarember K, Levy O, Elsbach P, Weiss J: Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest 1995, 95:1916-1924. One of two important contributions by this group (see Weinrauch et al. (J Clin Invest) 1996, 97:250-257) on the contribution of neutrophil-derived polypeptides to the antimicrobial activity of inflammatory fluids. This is an example of the "holistic" approach that examines the interaction of multiple polypeptides in a biological context. It is important to note that the specific proteins responsible for the antimicrobial activity of peritoneal fluid differ depending on the target organism tested.
15. Joiner KA, Ganz T, Albert J, Rotrosen D: The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes. J Cell Biol 1989, 109:2771-2782.
16. Stein DK, Malawista SE, Van Blaricom G, Wysong D, Diamond RD: Cytoplasts generate oxidants but require added neutrophil granule constituents for fungicidal activity against Candida albicans hyphae. J Infect Dis 1995, 172:511-520.
17. Frohm M, Gunne H, Bergman AC, Agerberth B, Bergman T, Boman A, Liden S, Jornvall H, Boman HG: Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 1996, 237:86-92.
18. Sengelov H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N: Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995, 154:4157-4165.
19. Ellison RT: The effects of lactoferrin on gram-negative bacteria. Adv Exp Med Biol 1994, 357:71-90.
20. Wang D, Pabst KM, Aida Y, Pabst MJ: Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J Leukoc Biol 1995, 57:865-874.
21. Odell EW, Sarra R, Foxworthy M, Chapple DS, Evans RW: Antibacterial activity of peptides homolgous to a loop region in human lactoferrin. FEBS Lett 1996, 382:175-178.
22. Turchany JM, Aley SB, Gillin FD: Glardicidal activity of lactoferrin and N-terminal peptides. Infect Immun 1995, 63:4550-4552.
23. Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J: Antibacterial proteins of granulocytes differ in interaction with endotoxin: comparison of bactericidal/permeability-increasing protein, p15s, and defensins. J Immunol 1995, 154:5403-5410.
24. Elsbach P, Weiss J: Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections. Infect Agents Dis 1995, 4:102-109.
25. von der Mohlen MA, Kimmings AN, Wedel NI, Mevissen ML, Jansen J, Friedmann N, Lorenz TJ, Nelson BJ, White ML, Bauer R: Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. J Infect Dis 1995, 172:144-151.
26. Jin H, Yang R, Marsters S, Ashkenazi A, Bunting S, Marra MN, Scott RW, Baker JB: Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats. J Clin Invest 1995, 95:1947-1952.
27. Qi SY, Li Y, Szyroki A, Giles IG, Moir A, O'Connor CD: Salmonella typhimurium responses to a bacterial protein from human neutrophils. Mol Microbiol 1995, 17:523-531.
28. Capodici C, Weiss J: Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function. J Immunol 1996, 156:4789-4796.
29. Gabay JE, Almeida RP: Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin. Curt Opin Immunol 1993, 5:97-102.
30. Zanetti M, Gennaro R, Romeo D: Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995, 374:1-5. A beautiful review from the discoverers of the cathelicidin family.
31. Qu XC, Harwig SS, Oren AM, Shafer WM, Lehrer RI: Susceptibility of Nelsseria gonorrhoeae to protegrins. Infect Immun 1996, 64:1240-1245.
32. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH: Fall-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995, 92:195-199.
33. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC: Human CAP18: a novel antimicrobial lipopolysaccaride-binding protein. Infect Immun 1995, 63:1291-1297.
34. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R: The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996, 238:325-332. The hCAP18/CAP18/FALL-39/LL-37 precursor protein (the first and possibly only human neutrophil cathelicidin) was more or less simultaneously found by three groups (see Cowland et al. [FEBS Lett 1985, 368:173-176]), anticipated by Larrick et al. (Infect Immun 1995, 63:1291-1297) and only purified in this study by Gudmundsson et al., generating a worse-than-usual profusion of names.
35. Yomogida S, Nagaoka I, Yamashita T: Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch Biochem Biophys 1996, 328:219-226.
36. Popsueva AE, Zinovjeva MV, Visser JWM, Zijlmans JM, Fibbe WE, Belyavsky AV: A novel murine cathelin-like protein expressed in bone marrow. FEBS Lett 1996, 391:5-8.
37. Harwig SS, Kokryakov VN, Swiderek KM, Aleshina GM, Zhao C, Lehrer RI: Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes. FEBS Lett 1995, 362:65-69.
38. Gudmundsson GH, Magnusson KP, Chowdhary BP, Johansson M, Andersson L, Boman HG: Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci U S A 1995, 92:7085-7089.
39. Zhao C, Ganz T, Lehrer RI: Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39. FEBS Lett 1995, 376:130-134.
40. Zhao C, Ganz T, Lehrer RI: The structure of porcine protegrin genes. FEBS Lett 1995, 368:197-202.
41. Bagella L, Scocchi M, Zanetti M: cDNA sequences of three sheep myeloid cathelicidins. FEBS Lett 1995, 376:225-228.
42. Mahoney MM, Lee AY, Brezinski-Caliguri DJ, Huttner KM: Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide. FEBS Lett 1995, 377:519-522.
43. 2 as a highly effective host defense protein.
44. 2 on a highly effective host defense protein.
45. 2 as a highly effective host defense protein.
46. Ganz T, Lehrer RI: Defensins. Pharmacol Ther 1995, 66:191-205.
47. Martin E, Ganz T, Lehrer RI: Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 1995, 58:128-136.
48. White SH, Wimley WC, Selsted ME: Structure, function, and membrane integration of defensins. Curr Opin Struct Biol 1995, 58:128-136.
49. Zimmerman GR, Legault P, Selsted ME, Pardi A: Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. Biochemistry 1995, 34:13663-13671. This structural study provided the first evidence that α- and β-defensins may be evolutionarily related.
50. Mallow EB, Harris A, Salzman N, Russell JP, De Bernardinis RJ, Ruchelli E, Bevins CL: Human enteric defensins: gene structure and developmental expression. J Biol Chem 1996, 271:4038-4045.
51. Selsted ME, Miller SI, Henschen AH, Ouellette AJ: Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol 1992, 118:929-936.
52. Eisenhauer PB, Harwig SS, Lehrer RI: Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun 1992, 60:3556-3565.
53. Russell JP, Diamond G, Tarver AP, Scanlin TF, Bevins CL: Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipoplysaccharide and tumor necrosis factor alpha. Infect Immun 1996, 64:1565-1568. Along with the paper by Schonwetter et al. (Science 1995, 267:1645-1648), this article definitively links defensin expression to inflammatory stimuli.
54. Schonwetter BS, Stolzenberg ED, Zasloff MA: Epithelial antibiotics induced at sites of inflammation. Science 1995, 267:1645-1648. Along with the article by Russell et al. (Infect Immun 1996, 64:1565-1568), this paper definitively links defensin expression to inflammatory stimuli.
55. Conlon JM, Sower SA: Isolation of a peptide structurally related to mammalian corticostatins from the lamprey Petromyzon marinus. Comp Biochem Physiol [B] 1996, 114:133-137. A possible glimpse of the earliest recognizable defensin antecedents in lower vertebrates.
56. Saito T, Kawabata S, Shigenaga T, Takayenoki Y, Cho J, Nakajima H, Hirata M, Iwanaga S: A novel big defensin identified in horseshoe crab hemoctyes: isolation, amino acid sequence, and antibacterial activity. J Biochem (Tokyo) 1995, 117:1131-1137.
57. Osborn RW, De Samblanx GW, Thevissen K, Goderis I, Torrekens S, Van Leuven F, Attenborough S, Rees SB, Broekaert WF: Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae. FEBS Lett 1995, 368:257-262.
58. Dimarcq JL, Hoffman D, Meister M, Bulet P, Lanot R, Reichhart JM, Hoffmann JA: Characterization and transcriptional profiles of a Drosophila gene encoding an Insect defensin: a study in Insect immunity. Eur J Biochem 1994, 221:201-209.
59. Shimoda M, Ohki K, Shimamolo Y, Kohashi O: Morphology of defensin-treated Staphylococcus aureus. Infect Immun 1995, 63:2886-2891.
60. Miyakawa Y, Ratnakar P, Rao AG, Costello ML, Mathieu-Costello O, Lehrer RI, Catanzaro A: In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun 1996, 64:926-932.
61. Groisman EA: How bacteria resist killing by host-defense peptides. Trends Microbiol 1994, 2:444-449.
62. McLeod GI, Spector MP: Starvation- and stationary-phase-induced resistance to the antimicrobial peptide polymyxin B in Salmonella typhimurium in RpoS (sigma(S)) independent and occurs through both phoP-dependent and -independent pathways. J Bacteriol 1996, 178:3683-3688.
63. Lichtenstein AK, Ganz T, Nguyen TM, Selsted ME, Lehrer RI: Mechanism of target cytolysis by peptide defensins: target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol 1988, 140:2686-2694.
64. Nygaard SD, Ganz T, Peterson MW: Defensins reduce the barrier integrity of a cultured epithelial monolayer without cytotoxicity. Am J Respir Cell Mol Biol 1993, 8:193-200.
65. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Dongo DL, Taub DD, Oppenheim JJ: Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996, 271:2935-2940.
66. Territo MC, Ganz T, Selsted ME, Lehrer R: Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 1989, 84:2017-2020.
67. Tominaga T, Fukata J, Naito Y, Nakai Y, Funakoshi S, Fujii N, Imura H: Effects of corticostatin-1 on rat adrenal cells in vitro. J Endocrinol 1990, 125:287-292.
68. Zhu QZ, Singh AV, Bateman A, Esch F, Solomon S: The coricostatic (anti-ACTH) and cytotoxic activity of peptides isolated from fetal, adult and tumor-bearing lung. J Steroid Biochem Mol Biol 1987, 27:1017-1022.
69. Higazi AA, Barghouti II, Abu-Much R: Identification of an inhibitor of tissue-type plasminogen activator-mediator fibrinolysis in human neutrophils: a role for defensin. J Biol Chem 1995, 270:9472-9477. This study identified a novel connection between inflammation and blood clotting that may help maintain a fibrin barrier around sites of infection.
70. Panyutich AV, Hiemstra PS, Van Wetering S, Ganz T: Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol 1995, 12:351-357.
71. Liu L, Ganz T: The pro region of human neutrophil defensin contains a motif that is essential for normal subcellular sorting. Blood 1995, 85:1095-1103. Many small antimicrobial peptides are produced as proteolytic fragments of much larger precursors. This article examines the functions of a defensin precursor, and the activities and interactions of its two domains.
72. Valore E, Maritn E, Harwig SS, Ganz T: Intramolecular inhibition of human defensin HNP-1 by its propiece. J Clin Invest 1996, 97:1624-1629. Many small antimicrobial peptides are produced as proteolytic fragments of much larger precursors. This article examines the functions of a defensin precursor, and the activities and interactions of its two domains.
73. Andersson M, Curstedt T, Jornvall H, Johansson J: An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett 1995, 362:328-332.
74. Leippe M: Ancient weapons: NK-lysln is a mammalian homolog to pore-forming peptides of a protozoan parasite. Cell 1995, 83:17-18.
75. Kelley KJ: Using host defenses to fight infectious diseases. Nat Biotech 1996, 14:587-689.